Slayback Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SLAYBACK, and what generic and branded alternatives to SLAYBACK drugs are available?
SLAYBACK has one approved drug.
Summary for Slayback
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| PTAB Cases with Slayback as petitioner: | See PTAB cases with Slayback as petitioner |
Drugs and US Patents for Slayback
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Slayback | LINCOMYCIN HYDROCHLORIDE | lincomycin hydrochloride | INJECTABLE;INJECTION | 063180-001 | Apr 16, 1991 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
